SEARCH

SEARCH BY CITATION

References

  • 1
    Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts: Overriding effects of HLA matching socioeconomic factors. N Engl J Med 1992; 327: 840845.
  • 2
    Chisholm MA, Villenweider LJ, Mulloy LL et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000; 70: 12401244.
  • 3
    Chisholm MA, Weishittel P. Strategies for improving adherence to posttransplant immunosuppressive regimens. Nephrology Updates 2005; 2: 19.
  • 4
    Paris W, Dunham S, Sebastian A, Jacobs C, Nour B. Medication nonadherence and its relation to financial restriction. J Transplant Coord 1999; 9: 149152.
  • 5
    Raiz LR, Kilty K, Henry ML, Ferguson RM. Medication compliance following renal transplantation. Transplantation 1999; 68: 5155.
  • 6
    Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004; 77: 769776.
  • 7
    Chisholm MA. Issues of adherence to immunosuppressant therapy after solid-organ transplantation. Drugs 2002; 62: 567575.
  • 8
    U.S. Department of Health and Human Services. Medicare and you 2006. Available at: http://www.medicare.gov/Publications/Pubs/pdf/10050.pdf. Accessed January 11, 2006.
  • 9
    Blum J, Bowman J, White C. The impact of enrollment in the Medicare prescription drug benefit program. The Henry J. Kaiser Family Foundation , 2005. Available at: http://www.kff.org/medicare/upload/The-Impact-of-Enrollment-in-the-Medicare-Prescription-Drug-Benefit-on-Premiums-Report.pdf. Accessed February 24, 2006.
  • 10
    70 Federal Register: 4529, January 28, 2005. §423.38.
  • 11
    The Henry J. Kaiser Family Foundation. Medicare. Medicare prescription drug plan information, by state, 2006 (fact sheet). Available at: http://www.kff.org/medicare/upload/74261.pdf. Accessed February 23, 2006.
  • 12
    The Henry J. Kaiser Family Foundation. Medicare. The Medicare prescription drug benefit (fact sheet). Available at: http://www.kff.org/medicare/upload/7044-02.pdf. Accessed February 23, 2006.
  • 13
    Centers for Medicare and Medicaid Services. Question ID 5795. Available at: http://questions.cms.hhs.gov. Accessed February 24, 2006.
  • 14
    National Kidney Foundation. Medicare prescription drug, improvement, and modernization act of 2003. Available at: http://www.kidney.org/news/pubpol/pdf/HR1.pdf. Accessed January 9, 2006.
  • 15
    Atherly A, Dowd BE. Effect of Medicare advantage payments on dually eligible Medicare beneficiaries. Health Care Financing Rev 2005; 26: 93104.
  • 16
    Medicare Payment Advisory Commission. Report to Congress: New approaches in Medicare. Washington , DC , June 2004b.
  • 17
    Red Book, 2005 Edition. Montvale , NJ : Thomson, 2005.
  • 18
    PeroutkaJ (ed.). Medicare part D: Creditable coverage disclosure notice. Rx Inform 2005; 4: 15.
  • 19
    Centers for Medicare and Medicaid Services. Question ID 5924. Available at: http://questions.cms.hhs.gov. Accessed February 23, 2006.